Merck's Keytruda likely to benefit from 'celebrity effect' after Jimmy Carter declared free of cancer

Former President Jimmy Carter has been declared free of cancer after receiving Merck's ($MRK) Keytruda and radiation therapy for his metastasized melanoma, and research shows that Merck is likely to get a boost in sales as a result. A number of studies have documented a proven celebrity effect in healthcare. One study showed after journalist Katy Couric had an on-air colonoscopy, there was a 21% increase in colorectal screenings the next month. Singer Kylie Minogue's breast cancer diagnosis was later linked to mammography screening increases of 40% in Australia. More from FiercePharmaMarketing

Suggested Articles

After early threats, the FDA finished reviewing the company's response to a citation for data manipulation and decided not to take any further action.

China is quickly getting back up to speed with API production but reports freight bottlenecks are slowing deliveries.

Mylan and Pfizer have already postponed the close of their generic merger amid COVID-19 concerns. Now the pair is hoping to speed up EU review.